By-Health Co., Ltd. is China's leading dietary supplement company, headquartered in Zhuhai, Guangdong Province, and listed on the Shenzhen Stock Exchange. The company operates a fully integrated business model encompassing research and development, self-production, branding, and multi-channel sales. With approximately 5,000 employees and a presence spanning 21 countries, By-Health has established itself as the dominant player in China's rapidly growing wellness and nutrition market.
Core Business
By-Health operates a comprehensive portfolio of dietary supplements and nutritional products, including vitamins, minerals, protein supplements, probiotics, meal replacements, and sports nutrition offerings. The company employs a strategic multi-brand architecture designed to capture distinct consumer segments. The flagship By-Health brand remains the cornerstone of the business, contributing approximately 70% of total revenue and maintaining its position as China's top dietary supplement brand. The Jointliff brand focuses on joint health solutions, while Life-Space has emerged as the company's fastest-growing segment, driven by surging demand for probiotic products and achieving 25.6% year-over-year growth. This diversified brand portfolio enables By-Health to serve a broad spectrum of health-conscious consumers while mitigating concentration risk.
Global Presence
While By-Health maintains its strongest market position in China, the company has expanded its footprint to 21 countries worldwide, with particular focus on Southeast Asian markets as part of its international growth strategy. Domestically, the company operates five core production bases with combined annual manufacturing capacity of 5 billion tablets and capsules, supporting its scale and supply chain resilience. The distribution network is strategically balanced across multiple channels, with pharmacy partners accounting for approximately 50% of sales, e-commerce platforms contributing 30%, and traditional retail channels representing the remaining 15%. East China and South China represent the company's most significant domestic markets, collectively accounting for approximately 55% of regional revenue.
Key Strengths
By-Health's competitive position is underpinned by substantial investment in research and development, with the company operating three dedicated R&D centers staffed by approximately 500 researchers. In 2024 alone, the company launched 120+ new products and secured 80 new patents, demonstrating a sustained commitment to innovation-driven growth. The company's robust brand equity is reflected in a brand heat score of 850 out of 1,000, indicating dominant market positioning and strong consumer loyalty. Financial performance remains solid, with 65% gross margins and consistent profitability, while the company's vertically integrated supply chain provides significant competitive advantages in quality control and cost management across its nutritional supplement portfolio.
